Detalhe da pesquisa
1.
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials.
BMC Cancer
; 24(1): 379, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528478
2.
Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles.
Proteomics
; : e2300025, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037300
3.
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials.
Oncologist
; 28(4): e205-e211, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905578
4.
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
BMC Med
; 21(1): 400, 2023 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872545
5.
Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs.
Rheumatology (Oxford)
; 62(2): 583-595, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731132
6.
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150.
Br J Cancer
; 126(1): 42-47, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711947
7.
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib.
Oncologist
; 26(7): 562-568, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914991
8.
Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition.
Drug Metab Dispos
; 49(11): 961-971, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34353847
9.
Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy.
J Natl Compr Canc Netw
; 19(9): 1037-1044, 2021 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951613
10.
Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy.
Int J Cancer
; 147(11): 3085-3089, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32492185
11.
Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials.
BMC Cancer
; 20(1): 157, 2020 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32103736
12.
Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab.
J Natl Compr Canc Netw
; 18(9): 1191-1199, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886899
13.
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients.
Int J Clin Oncol
; 25(9): 1672-1677, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417993
14.
Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients.
Breast Cancer Res Treat
; 178(2): 473-477, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399933
15.
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.
BMC Med
; 16(1): 165, 2018 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30261889
16.
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.
Br J Cancer
; 117(7): 913-920, 2017 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950287
17.
Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052851
18.
Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide Concentration.
Drug Metab Dispos
; 45(1): 8-16, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742727
19.
Regarding the Article by Rugo et al.
Oncologist
; 26(7): e1285, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33818868
20.
Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis.
Br J Clin Pharmacol
; 81(1): 113-23, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331989